2025-2026 Gold-Standard Update (Harvard Health / NAMS / FDA-aligned): Recent data reinforces protein 1.6g+/kg + resistance training as top levers for midlife (Pontzer, Walker). FDA/HHS 2025 updates on MHT timing benefit body comp. GLP-1 synergy. Individualize with labs (ferritin, insulin, DEXA). Sources: NEJM, NAMS, 2025 reviews.
12 questions to ask · 4 labs to request · Updated June 2026
This is the exact list we wish every woman walking into a perimenopause appointment had with her. It works whether your clinician is NAMS-certified or a generalist. Bring it printed. The act of having it on paper changes the conversation.
Goal: leave with an evidence-based decision, not a deflection.
The 12 questions
Confirm training: "Are you menopause-society certified, and how recently did you update your HRT protocols?"
Position-statement alignment: "Do you follow the 2022 NAMS position statement on HRT for symptomatic women under 60?"
Timing window: "Based on my symptoms and timing, am I in the window where the risk-benefit ratio favors HRT?"
Delivery preference: "What's your view on transdermal versus oral estrogen for my profile?"
Progesterone choice: "If I have a uterus, would you prescribe micronized progesterone rather than synthetic progestin? Why or ohy not?"
Dose philosophy: "What's the lowest effective dose you'd consider starting me at, and how would we titrate?"
Symptom targeting: "Beyond hot flashes, which of my symptoms (sleep, mood, cognition, joint pain, sexual function) do you expect HRT to address?"
Monitoring schedule: "What's your follow-up schedule for the first 12 months — labs, symptom reviews, mammogram?"
Risk-personalization: "Given my personal and family history, what's the calculated risk-benefit, and how does it compare to the population numbers?"
Exit plan: "What's the protocol if I want to taper off in 5-7 years, and how do we make that decision together?"
Local-symptom track: "If systemic HRT isn't right for me, what's your view on vaginal estrogen for genitourinary symptoms? (It has a different risk profile.)"
Lifestyle layering: "What lifestyle interventions amplify HRT's effects in your experience — and which ones do you consider essential alongside it?"
The 4 labs to request
1. FSH (Follicle-Stimulating Hormone)
Confirms menopausal status. Often elevated above 30 mIU/mL in menopause. Less useful in perimenopause where it fluctuates — but worth the baseline.
2. Estradiol (E2)
Baseline ovarian output. Useful for trending once HRT begins. Levels under 30 pg/mL are typical post-menopause; HRT typically aims for 50-100 pg/mL on transdermal.
3. TSH + Free T4
Perimenopause and hypothyroidism share many symptoms. Rule out the thyroid story before assuming the hormone story.
4. Lipid panel + fasting glucose / HbA1c
Baseline cardiometabolic risk affects HRT decision-making. Modern HRT may improve cardiovascular markers when started in the right window — measure to see.
One more thing. If your clinician dismisses any of these questions, asks why you're "obsessing" about hormones, or quotes the 2002 WHI uncritically — book a second opinion with a NAMS-certified clinician. The North American Menopause Society maintains a public directory at menopause.org/for-women/find-a-menopause-practitioner. The directory is free. The conversation is worth the trip.
2027 Pro Tips for This Topic
Track your progress with Oura or similar. Reassess every 90 days. Combine with resistance training and protein for best results. This is decision-grade, not fluff – use the linked tools and letter sequence.